The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Reduction of Respiratory Syncytial Virus Hospitalization Among Premature Infants and Infants With Bronchopulmonary Dysplasia Using Respiratory Syncytial Virus Immune Globulin Prophylaxis
Abstract
Objective. To determine the safety and efficacy of monthly prophylaxis with respiratory syncytial virus immune globulin, intravenous (RSV-IGIV) for reduction of the incidence of RSV-associated hospitalization. Methods. A randomized, double-blind, placebo-controlled clinical trial was conducted at 54 centers in the United States during the 1994 to 1995 RSV season. A total of 510 children with bronchopulmonary dysplasia and/or a history of prematurity were randomized to receive either 750 mg/kg RSV-IGIV (n = 250) or placebo (1% albumin; n = 260) intravenously every 30 days. Randomized groups were well balanced at entry for demographics, RSV risk factors, and birth characteristics. Children were monitored for adverse events and for RSV-associated hospitalization from randomization through 30 days after the last infusion visit; serious adverse events were monitored for an additional 30 days. For children hospitalized with RSV, data were collected regarding the total days of RSV stay, total days of increased oxygen requirement, total days with a moderate or severe lower respiratory tract illness, and frequency and duration of intensive care unit stay and mechanical ventilation. Ninety-five percent of participants completed the protocol and 85% received a complete course of infusions. Results. The incidence of RSV hospitalization was reduced by 41% in children receiving RSV-IGIV prophylaxis; 35 (13.5%) of the children in the placebo group were hospitalized for RSV, compared with 20 (8.0%) RSV-IGIV recipients. RSV-IGIV recipients had a 53% reduction in the total number of RSV hospital days per 100 children, a 60% reduction in the number of RSV days with increased oxygen requirement, and a 54% reduction in the number of RSV hospital days with a moderate or severe lower respiratory tract illness. In addition, children receiving RSV-IGIV had a 38% reduction in hospitalization for respiratory illness of any cause and a 46% reduction in total hospital days for respiratory illness per 100 children. RSV-IGIV was safe and well tolerated, with a safety profile similar to other IGIV preparations. Between 1% to 3% of children had medically significant adverse events related to RSV-IGIV administration. Conclusions. Monthly administration of 750 mg/kg of RSV-IGIV was safe and well tolerated and was effective in reducing the incidence and total days of both RSV hospitalization and overall respiratory hospitalization in infants with a history of prematurity or bronchopulmonary dysplasia or both.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risk of Primary Infection and Reinfection With Respiratory Syncytial Virus
Glezen, W. P. (1986) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.1986.02140200053026 · Cited by 1,527
Groothuis, J. R., Simoes, E., Levin, M. J., Hall, C. B., Long, C. E., Rodriguez, W. J., Arrobio, J., Meissner, H. C., Fulton, D. R., Welliver, R. C., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311183292102 · Cited by 744
Glezen, W. P., Paredes, A., Allison, J. E., Taber, L. H., & Frank, A. L. (1981) · The Journal of Pediatrics · doi:10.1016/s0022-3476(81)80829-3 · Cited by 689
Epidemiology of Acute Lower Respiratory Disease in Children
Glezen, W. P., & Denny, F. W. (1973) · New England Journal of Medicine · doi:10.1056/nejm197303082881005 · Cited by 614
Respiratory Syncytial Viral Infection in Infants with Congenital Heart Disease
MacDonald, N. E., Hall, C. B., Suffin, S. C., Alexson, C., Harris, P. J., & Manning, J. A. (1982) · New England Journal of Medicine · doi:10.1056/nejm198208123070702 · Cited by 608
EPIDEMIOLOGY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION IN WASHINGTON, D.C.
PARROTT, R. H., KIM, H. W., ARROBIO, J. O., HODES, D. S., MURPHY, B. R., BRANDT, C. D., CAMARGO, E., & CHANOCK, R. M. (1973) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a121558 · Cited by 449
Respiratory Syncytial Virus Infection in Children With Bronchopulmonary Dysplasia
Groothuis, J. R., Gutierrez, K. M., & Lauer, B. A. (1988) · PEDIATRICS · doi:10.1542/peds.82.2.199 · Cited by 377
Prince, G. A., Horswood, R. L., & Chanock, R. M. (1985) · Journal of Virology · doi:10.1128/jvi.55.3.517-520.1985 · Cited by 245
Rehospitalization for Respiratory Illness in Infants of Less Than 32 Weeks' Gestation
Cunningham, C. K., McMillan, J. A., & Gross, S. J. (1991) · PEDIATRICS · doi:10.1542/peds.88.3.527 · Cited by 242
Fanaroff, A. A., Korones, S. B., Wright, L. L., Wright, E. C., Poland, R. L., Bauer, C. B., Tyson, J. E., Philips, J. B., Edwards, W., Lucey, J. F., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404213301602 · Cited by 186
Intravenous Immune Globulin for the Prevention of Nosocomial Infection in Low-Birth-Weight Neonates
Baker, C. J., Melish, M. E., Hall, R. T., Casto, D. T., Vasan, U., & Givner, L. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207233270401 · Cited by 156
Siber, G. R., Leombruno, D., Leszczynski, J., McIver, J., Bodkin, D. K., Gonin, R., Thompson, C. M., Walsh, E. E., Piedra, P. A., Hemming, V. G., et al. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.6.1368 · Cited by 125
SIMOES, E. A. F., Groothuis, J. R., Tristram, D. A., Allessi, K., Lehr, M. V., Siber, G. R., & Welliver, C. (1996) · The Journal of Pediatrics · doi:10.1016/s0022-3476(96)70245-7 · Cited by 108
Siber, G. R., Leszczynski, J., Peña‐Cruz, V., Ferren-Gardner, C., Anderson, R. L., Hemming, V. G., Walsh, E. E., Burns, J. C., McIntosh, K., Gonin, R., et al. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/165.3.456 · Cited by 105
Intravenous immune globulin therapy for early-onset sepsis in premature neonates
Weisman, L. E., Stoll, B. J., Kueser, T. J., Rubio, T. T., Frank, C. G., Heiman, H. S., Subramanian, K. N. S., Hankins, C. T., Anthony, B. F., Cruess, D. F., et al. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81802-5 · Cited by 92
Cited by
The IMpact-RSV Study Group (1998) · Pediatrics · doi:10.1542/peds.102.3.531 · Cited by 1,961
Self-citationApproved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid
Boyce, T. G., Mellen, B. G., Mitchel, E. F., Wright, P. F., & Griffin, M. R. (2000) · The Journal of Pediatrics · doi:10.1067/mpd.2000.110531 · Cited by 688
Respiratory syncytial virus infection
Simoes, E. A. (1999) · The Lancet · doi:10.1016/s0140-6736(99)80040-3 · Cited by 603
Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment
Griffiths, C., Drews, S. J., & Marchant, D. J. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00010-16 · Cited by 586
Metadata
- Authors
- The PREVENT Study Group
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 1997-01-01
- Volume
- 99
- Issue
- 1
- Pages
- 93-99
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W4245170709
- Cited by
- 450
- References
- 15
- FWCI
- 31.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.